Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value:
$427.33M
Total Bought:
$104.8K
Total Sold:
$1.44M
Net Transaction:
-$1.34M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc.2,449,1832,449,1830$84.86M$110.21M25.79%+$25.35M
Rapport Therapeutics, Inc.(RAPP)2,498,0512,498,0510$58.10M$51.16M11.97%-$6.94M
Legend Biotech CorporationADS(LEGN)814,586814,5860$36.08M$39.69M9.29%+$3.62M
Contineum Therapeutics, Inc.CL A(CTNM)1,979,1731,979,1730$34.85M$37.88M8.86%+$3.03M
CVRx, Inc.(CVRX)4,103,4304,103,4300$49.20M$36.15M8.46%-$13.05M
Nanobiotix S.A.ADS(NBTX)5,623,8165,623,8160$28.12M$32.34M7.57%+$4.22M
PROCEPT BioRobotics Corporation(PRCT)357,939357,9390$21.87M$28.68M6.71%+$6.81M
MeiraGTx Holdings plc(MGTX)6,641,0646,641,0640$27.96M$27.69M6.48%-$265.6K
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,4450$18.18M$24.43M5.72%+$6.25M
Xencor, Inc.(XNCR)748,062748,0620$14.16M$15.04M3.52%+$882.7K
Fate Therapeutics, Inc.(FATE)3,379,0643,379,0640$11.08M$11.83M2.77%+$743.4K
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,5980$6.44M$4.80M1.12%-$1.64M
Rallybio Corporation(RLYB)3,636,3633,636,3630$4.87M$4.25M1.00%-$618.2K
Nano-X Imaging Ltd.
ORD SHS
158,852158,8520$1.17M$965.8K0.23%-$200.2K
Vor Biopharma Inc.(VOR)1,074,6581,074,6580$1.07M$752.3K0.18%-$322.4K
Standard BioTools Inc.(LAB)311,967311,9670$552.2K$602.1K0.14%+$49.9K
Adicet Bio, Inc.364,472364,4720$441.0K$524.8K0.12%+$83.8K
Tessera Defense and Homeland Security Inc.(HLSQ)1,923,201192,321-1,730,880$646.4K$196.2K0.05%-$450.2K
Clearside Biomedical, Inc.082,481+82,481$0$104.8K0.02%+$104.8K
Senseonics Holdings, Inc.(SENS)54,62154,6210$21.8K$19.1K0.00%-$2.7K
Aldeyra Therapeutics, Inc.(ALDX)299,6690-299,669$991.9K$0—-$991.9K
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q3 2024 | TickerTrail